The company believes, this investment commitment across AstraZeneca's business footprint in India will make a positive impact. It also aligns closely with the government's vision for healthcare and innovation, Wang said.

This investment commitment will be aimed at strengthening manufacturing, clinical operations, patient safety and regulatory science, IT services and commercial operations, AstraZeneca said.